OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Priming with LSD1 inhibitors promotes the persistence and antitumor effect of adoptively transferred T cells
Fengqi Qiu, Peishan Jiang, Guiheng Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10

Showing 10 citing articles:

Leveraging non-enzymatic functions of LSD1 for novel therapeutics
Yihui Song, Bin Yu
Trends in Pharmacological Sciences (2025)
Closed Access | Times Cited: 1

Epigenetic regulators combined with tumour immunotherapy: current status and perspectives
Huan Zhang, Yuepeng Pang, Ling Yi, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access

The mouse resource at National Resource Center for Mutant Mice of China
Bingzhou Han, Dongshen Chen, Zhong Chen, et al.
Mammalian Genome (2025)
Open Access

PD-L1/PD-1 checkpoint pathway regulates astrocyte morphogenesis and myelination during brain development
Yanyan Wang, Mengtian Zhang, Tianyu Zhang, et al.
Molecular Psychiatry (2025)
Closed Access

T cell-based cancer immunotherapy: opportunities and challenges
Kaili Ma, Yingxi Xu, Hongcheng Cheng, et al.
Science Bulletin (2025)
Closed Access

Evolving CAR T-Cell Therapy to Overcome the Barriers in Treating Pediatric Central Nervous System Tumors
Andrea Timpanaro, Edward Song, Nour Emwas, et al.
Cancer Discovery (2025) Vol. 15, Iss. 5, pp. 890-902
Closed Access

LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8+ T cell responsiveness
Isabella Pallavicini, Teresa M. Frasconi, Carlotta Catozzi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3

Cancer epigenetic therapy: recent advances, challenges, and emerging opportunities
Rajita Vatapalli, Alex P. Rossi, Ho Man Chan, et al.
Epigenomics (2024), pp. 1-16
Open Access | Times Cited: 3

Promising therapy for neuroendocrine prostate cancer: current status and future directions
Fei Xin, Jia-Wei Xue, Ji-zhongrong Wu, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 1

Page 1

Scroll to top